Publications

2017

  1. Sano K, Ichikawa T, Motosugi U, Ichikawa S, Morisaka H, Enomoto N, Matsuda M, Fujii H:Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis. Eur Radiol, 27 (2): 518-525. 2017. PubMed »
  2. McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, Reeder SB, Sirlin CB, Bashir MR:Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. Radiology, 282 (2): 361-368. 2017.  PubMed » 

 

2016

  1. Ichikawa S, Motosugi U, Enomoto N, Matsuda M, Onishi H:Noninvasive hepatic fibrosis staging using mr elastography: The usefulness of the bayesian prediction method. J Magn Reson Imaging, 2016.  [Epub ahead of print]  PubMed »
  2. Morisaka H, Motosugi U, Glaser KJ, Ichikawa S, Ehman RL, Sano K, Ichikawa T, Onishi H:Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. J Magn Reson Imaging, 2016. [Epub ahead of print]  PubMed »
  3. Motosugi U, Ichikawa T, Sano K, Onishi H:Acute Adverse Reactions to Nonionic Iodinated Contrast Media for CT: Prospective Randomized Evaluation of the Effects of Dehydration, Oral Rehydration, and Patient Risk Factors. AJR Am J Roentgenol, 207 (5): 931-938. 2016. PubMed »
  4. Bannas P, Roldan-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H:Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging. Radiology, 281 (2): 574-582. 2016. PubMed »
  5. Takamura T, Motosugi U, Ichikawa S, Sano K, Morisaka H, Ichikawa T, Enomoto N, Onishi H:Usefulness of MR elastography for detecting clinical progression of cirrhosis from child-pugh class A to B in patients with type C viral hepatitis. J Magn Reson Imaging, 44 (3): 715-22. 2016. PubMed »
  6. Matsuda S, Motosugi U, Kato R, Muraoka M, Suzuki Y, Sato M, Shindo K, Nakayama Y, Inoue T, Maekawa S, Sakamoto M, Enomoto N:Hepatic Amyloidosis with an Extremely High Stiffness Value on Magnetic Resonance Elastography. Magn Reson Med Sci, 15 (3): 251-2. 2016.  PubMed » 
  7. Satoh Y, Motosugi U, Nambu A, Saito A, Onishi H:Prognostic Value of Semiautomatic CT Volumetry in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. J Comput Assist Tomogr, 40 (3): 343-50. 2016. PubMed »  
  8. Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, Matsuda M, Fujii H, Onishi H:Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma. Magn Reson Med Sci, 15 (1): 49-59. 2016.  PubMed »
  9. Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB:An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology, 279 (1): 93-102. 2016.  PubMed »
  10. Bannas P, Motosugi U, Hernando D, Rahimi MS, Holmes JH, Reeder SB:Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study. Magn Reson Med, 75 (1): 318-28. 2016.  PubMed »
  11. Sciarra A, Di Tommaso L, Nakano M, Destro A, Torzilli G, Donadon M, Maggioni M, Bosari S, Bulfamante G, Matsuda M, Fujii H, Ichikawa T, Morisaka H, Sano K, Ichikawa S, Roncalli M:Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications. J Hepatol, 64 (1): 87-93. 2016.  PubMed »
  12. Bannas P, Bell LC, Johnson KM, Schiebler ML, Francois CJ, Motosugi U, Consigny D, Reeder SB, Nagle SK:Pulmonary Embolism Detection with Three-dimensional Ultrashort Echo Time MR Imaging: Experimental Study in Canines. Radiology, 278 (2): 413-21. 2016.   PubMed »

2015

  1. Motosugi U:Gadoxetic Acid-induced Acute Transient Dyspnea: The Perspective of Japanese Radiologists. Magn Reson Med Sci, 14 (2): 163-4. 2015. PubMed »
  2. Motosugi U, Hernando D, Bannas P, Holmes JH, Wang K, Shimakawa A, Iwadate Y, Taviani V, Rehm JL, Reeder SB:Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI. J Magn Reson Imaging, 42 (5): 1241-8. 2015 PubMed »
  3. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL:Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol, 13 (3): 440-451 e6. 2015.  PubMed »
  4. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, Enomoto N, Matsuda M, Fujii H, Onishi H:Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging, 33 (1): 26-30. 2015.   PubMed »
  5. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H: Validity and reliability of magnetic resonance elastography for staging hepatic fibrosis in patients with chronic hepatitis B. Magn Reson Med Sci, 14(3):211-21. 2015.  PubMed »
  6. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H:Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images? Liver Cancer, 4 (3): 154-62. 2015. PubMed »   
  7. Motosugi U, Bannas P, Sano K, Reeder SB:Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging, 41 (2): 251-65. 2015. PubMed »
  8. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Enomoto N:Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease. J Magn Reson Imaging, 41 (1): 117-24. 2015. PubMed »
  9. Ichikawa S, Motosugi U, Nakazawa T, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H:Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging, 41 (5): 1203-8. 2015. PubMed »
  10. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H:MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.  J Magn Reson Imaging, 42 (1): 204-10. 2015.  PubMed »

 

2014

  1. Matsuda M, Ichikawa T, Amemiya H, Maki A, Watanabe M, Kawaida H, Kono H, Sano K, Motosugi U, Fujii H:Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection. HPB Surg, 2014: 641685. 2014. [Epub ahead of print] PubMed »
  2. Matsuda M, Amemiya H, Kawaida H, Okamoto H, Hosomura N, Asakawa M, Sano K, Motosugi U, Ichikawa T, Nakazawa T, Fujii H:Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case. Surg Today, 44 (7): 1359-66. 2014. PubMed »
  3. Ichikawa T, Sano K, Morisaka H:Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus. Liver Cancer, 3 (2): 97-107. 2014. PubMed »
  4. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T:Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. J Magn Reson Imaging, 39 (2): 293-7. 2014. PubMed »
  5. Ichikawa S, Ichikawa T, Motosugi U, Imaizumi A, Sano K, Morisaka H:Computed Tomography (CT) Venography With Dual-Energy CT: Low Tube Voltage and Dose Reduction of Contrast Medium for Detection of Deep Vein Thrombosis. J Comput Assist Tomogr, 38 (5): 797-801. 2014. PubMed »
  6. Fatima Z, Ichikawa T, Ishigame K, Motosugi U, Waqar AB, Hori M, Iijima H, Araki T:Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol, 24 (2): 129-34. 2014. PubMed »

 

2013

  1. Muhi A, Ichikawa T, Motosug U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T:Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int, 7 (2): 662-8. 2013.
  2. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Morisaka H, Ichikawa S, Enomoto N, Matsuda M, Fujii H, Araki T:Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study. Eur Radiol, 23 (1): 156-62. 2013. PubMed »
  3. Motosugi U, Ichikawa T, Araki T, Matsuda M, Fujii H, Enomoto N:Bayesian prediction for liver fibrosis staging: Combined use of elastography and serum fibrosis markers. Hepatology, 58 (1): 450-1. 2013. PubMed »
  4. Motosugi U:Hypovascular hypointense nodules on hepatocyte phase gadoxetic acid-enhanced MR images: too early or too progressed to determine hypervascularity. Radiology, 267 (1): 317-8. 2013. PubMed »
  5. Motosgui U, Ichikawa T, Araki T:Rules, Roles, and Room for Discussion in Gadoxetic Acid-enhanced Magnetic Resonance Liver Imaging: Current Knowledge and Future Challenges. Magn Reson Med Sci, 12 (3): 161-75. 2013. PubMed »
  6. Morisaka H, Motosugi U, Ichikawa T, Sano K, Ichikawa S, Araki T, Enomoto N:MR-based Measurements of Portal Vein Flow and Liver Stiffness for Predicting Gastroesophageal Varices. Magn Reson Med Sci, 12 (2): 77-86. 2013. PubMed »
  7. Ichikawa T, Okada M, Kondo H, Sou H, Murakami T, Kanematsu M, Yoshikawa S, Shiosakai K, Hayakawa A, Awai K, Yoshimitsu K, Yamashita Y:Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan. Acad Radiol, 20 (9): 1130-6. 2013. PubMed »
  8. Ichikawa T, Motosugi U, Morisaka H, Sano K, Muhi A, Araki T:Volumetric low-tube-voltage CT imaging for evaluating hypervascular hepatocellular carcinoma; effects on radiation exposure, image quality, and diagnostic performance. Jpn J Radiol, 31 (8): 521-9. 2013. PubMed »
  9. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T:Intravoxel incoherent motion imaging of focal hepatic lesions. J Magn Reson Imaging, 37 (6): 1371-6. 2013. PubMed »
  10. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T:Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging, 31 (3): 414-7. 2013. PubMed »
  11. Fatima Z, Motosugi U, Waqar AB, Hori M, Ishigame K, Oishi N, Onodera T, Yagi K, Katoh R, Araki T:Associations among q-space MRI, diffusion-weighted MRI and histopathological parameters in meningiomas. Eur Radiol, 23 (8): 2258-63. 2013. PubMed »
  12. Fatima Z, Motosugi U, Muhi A, Hori M, Ishigame K, Araki T:Diffusion-weighted imaging in optic neuritis. Can Assoc Radiol J, 64 (1): 51-5. 2013. PubMed »
  13. Fatima Z, Motosugi U, Hori M, Onodera T, Ishigame K, Yagi K, Araki T:Age-related white matter changes in high b-value q-space diffusion-weighted imaging. Neuroradiology, 55 (3): 253-9. 2013. PubMed »
  14. Fatima Z, Ishigame K, Araki T:Case 193. Radiology, 266 (1): 355-6. 2013. PubMed »
  15. Fatima Z, Ishigame K, Araki T:Case 193: Neuroferritinopathy–a brain iron accumulation and neurodegenerative disorder. Radiology, 267 (2): 650-5. 2013. PubMed »
  16. Chen N, Motosugi U, Sano K, Ichikawa T, Nakano M, Morisaka H, Ichikawa S, Matsuda M, Fujii H, Enomoto N, Araki T:Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic Acid-enhanced, hepatocyte-phase magnetic resonance images. J Comput Assist Tomogr, 37 (3): 466-9. 2013. PubMed »

2012

  1. Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Tsukamoto T, Fatima Z, Araki T:Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging, 35 (4): 827-36. 2012. PubMed »
  2. Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Araki T:Diffusion- and T2 -weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci, 11 (3): 185-91. 2012. PubMed »
  3. Muhi A, Ichikawa T, Motosugi U:Gadoxetic acid-enhanced MRI:a method for the detection of hepatic metastases. Imaging Med, 4 (3): 279-86. 2012.
  4. Motosugi U, Yamaguchi H, Furukawa T, Ichikawa T, Hatori T, Fujita I, Yamamoto M, Motoi F, Kanno A, Watanabe T, Koike N, Koyama I, Kobayashi J, Shimizu M:Imaging Studies of Intraductal Tubulopapillary Neoplasms of the Pancreas: 2-Tone Duct Sign and Cork-of-Wine-Bottle Sign as Indicators of Intraductal Tumor Growth. J Comput Assist Tomogr, 36 (6): 710-17. 2012. PubMed »
  5. Motosugi U, Ichikawa T, Sou H, Sano K, Muhi A, Ehman RL, Araki T:Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging, 30 (1): 128-32. 2012. PubMed »
  6. Motosugi U, Ichikawa T, Sou H, Morisaka H, Sano K, Araki T:Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: Preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients. Eur J Radiol, 81 (10): 2533-7. 2012. PubMed »
  7. Motosugi U, Ichikawa T, Muhi A, Sano K, Morisaka H, Ichikawa S, Araki T:Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease. Invest Radiol, 47 (10): 566-70. 2012. PubMed »
  8. Motosugi U, Ichikawa T, Amemiya F, Sou H, Sano K, Muhi A, Enomoto N, Araki T:Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement: discrepancy in the results of cirrhotic liver. J Magn Reson Imaging, 35 (3): 607-10. 2012. PubMed »
  9. Ichikawa T, Motosugi U, Morisaka H, Sou H, Onohara K, Sano K, Araki T:Optimal iodine dose for 3-dimensional multidetector-row CT angiography of the liver. Eur J Radiol, 81 (9): 2450-5. 2012. PubMed »
  10. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T:Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci, 11 (4): 291-7. 2012. PubMed »
  11. Haradome H, Grazioli L, Al manea K, Tsunoo M, Motosugi U, Kwee TC, Takaraha T:Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging, 35 (1): 132-9. 2012. PubMed »
  12. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S:Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 262 (2): 520-9. 2012. PubMed »
  13. Fatima Z, Motosugi U, Okumura A, Ishigame K, Araki T:Basi-parallel Anatomical Scanning (BPAS)-MRI Can Improve Discrimination of Vertebral Artery Dissection from Atherosclerosis and Hypoplasia. Acad Radiol, 19 (11): 1362-7. 2012. PubMed »
  14. Fatima Z, Motosugi U, Hori M, Ishigame K, Onodera T, Yagi K, Araki T:High b-Value q-Space Analyzed Diffusion-Weighted MRI Using 1.5 Tesla Clinical Scanner; Determination of Displacement Parameters in the Brains of Normal versus Multiple Sclerosis and Low-Grade Glioma Subjects. J Neuroimaging, 22 (3): 279-84. 2012. PubMed »

2011

  1. Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, Araki T:Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol, 196 (2): 447-53. 2011. PubMed »
  2. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, Nakano M, Sakamoto M, Nakazawa T, Asakawa M, Fujii H, Kitamura T, Enomoto N, Araki T:Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology, 261 (3): 834-44. 2011. PubMed »
  3. Nambu A, Sawada E, Kato S, Araki T, Aikawa Y, Yuge M, Saito A:Determination of a standard deviation that could minimize radiation exposure in an automatic exposure control for pulmonary thin-section computed tomography. Japanese Journal of  Radiology, 29 (6): 405-12. 2011. PubMed »
  4. Nambu A, Onishi H, Aoki S, Koshiishi T, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Tominaga L, Maehata Y, Sawada E, Araki T:Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients. Radiat Oncol, 6: 137. 2011. PubMed »
  5. Nakazawa T, Kondo T, Yuminomochi T, Nakazawa K, Ishii Y, Mochizuki K, Kawasaki T, Yamane T, Miyata M, Motosugi U, Katoh R:Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol, 39 (3): 218-22. 2011. PubMed »
  6. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T:Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging, 34 (2): 326-35. 2011. PubMed »
  7. Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Kitamura T, Amemiya F, Enomoto N, Matsuda M, Asakawa M, Fujii H, Araki T:Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol, 46 (2): 141-5. 2011. PubMed »
  8. Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Amemiya F, Enomoto N, Matsuda M, Fujii H, Araki T:Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. Journal of  Magnetic Resonance Imaging, 34 (1): 88-94. 2011. PubMed »
  9. Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, Muhi A, Araki T:Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Investigative Radiology, 46 (6): 359-65. 2011. PubMed »
  10. Motosugi U, Ichikawa T, Oguri M, Sano K, Sou H, Muhi A, Matsuda M, Fujii H, Enomoto N, Araki T:Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging, 29 (8): 1047-52. 2011. PubMed »
  11. Motosugi U, Ichikawa T, Niitsuma Y, Araki T:Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness? Jpn J Radiol, 29 (9): 639-43. 2011. PubMed »
  12. Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, Sano K, Araki T:Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology, 260 (2): 446-53. 2011. PubMed »
  13. Hori M, Motosugi U, Fatima Z, Kumagai H, Ikenaga S, Ishigame K, Aoki S, Onodera T, Yagi K, Araki T:A comparison of mean displacement values using high b-value Q-space diffusion-weighted MRI with conventional apparent diffusion coefficients in patients with stroke. Acad Radiol, 18 (7): 837-41. 2011. PubMed »
  14. Hori M, Motosugi U, Fatima Z, Ishigame K, Araki T:Mean displacement map of spine and spinal cord disorders using high b-value q-space imaging-feasibility study. Acta Radiol, 52 (10): 1155-8. 2011. PubMed »
  15. Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S:Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging, 34 (1): 69-78. 2011. PubMed »
  16. Fatima Z, Ichikawa T, Motosugi U, Muhi A, Sano K, Sou H, Haradome H, Kiryu S, Araki T:Magnetic resonance diffusion-weighted imaging in the characterization of pancreatic mucinous cystic lesions. Clin Radiol, 66 (2): 108-11. 2011. PubMed »